“If the Pharma industry doesn’t reinvent itself and its processes, it will become nothing but a supplier to Big Tech, which is rapidly moving into healthcare,” says Paul Simms, CEO and Founder of Eyeforpharma. Paul does believe Pharma companies are putting effort into adopting and helping develop DTx. But as DTx are in their early days of development and adoption, we will see a lot more failures before a universal system will be identified and put in place.

Read More